US Stocks
/
Cingulate Inc. Share Price

Cingulate Inc. Share Price

NASDAQ: CING | Micro Cap
$4.91
-$0.02 (-0.41%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cingulate Inc. Stock Performance

Open
$4.84
Prev. Close
$4.93
Circuit Range
N/A
Day Range
$4.78 - $4.92
Year Range
$3.19 - $11.78
Volume
4,508
Average Traded
$4.88

Cingulate Inc. Share Price Today

As of 9 October 2026, Cingulate Inc.'s share price is $4.91. The stock opened at $4.84, compared to its previous close of $4.93. During today's trading session, Cingulate Inc.'s share price traded between $4.78 and $4.92, with an average price of $4.85. Over the past 52 weeks, the stock has recorded a high of $11.78 and a low of $3.19. In terms of performance, Cingulate Inc.'s share price has declined by 4.01% over the last six months and is up 30.07% on a year-on-year basis.

Cingulate Inc. Share Price Chart

$4.78$4.92
L
Show Current Price
H

Cingulate Inc. Stock Fundamentals & Key Indicators

Market Cap
$24.82M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.98
Revenue (TTM)
$0.00
Return On Equity (TTM)
-122.71%
Profit Margin
N/A
Debt to Equity
0.22
Quarterly Earnings Growth YoY
20.03%

Cingulate Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.34-$6.27-$9.31-$5.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A14.58%-48.48%36.95%

Cingulate Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.68-$23.53-$16.56-$22.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-33.09%29.62%-35.57%

About Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Cingulate Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.80
$4.90
-1.01%
Sep 2026
$5.16
$4.95
-8.16%
Aug 2026
$4.87
$5.39
+12.76%
Jul 2026
$5.63
$4.78
-12.29%
Jun 2026
$3.29
$5.45
+32.12%
May 2026
$5.16
$4.13
-19.35%
Apr 2026
$6.38
$5.12
-16.90%
Mar 2026
$6.01
$6.16
-1.83%
Feb 2026
$5.87
$6.27
+9.62%
Jan 2026
$4.31
$5.72
+32.71%
Dec 2025
$3.65
$4.31
+16.02%
Nov 2025
$3.69
$3.71
-1.59%

CING Share Price FAQs

What is Cingulate Inc. share price today?

chevron-up
Cingulate Inc. share price today is $4.91 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cingulate Inc. stock?

chevron-up
The 52 week high of Cingulate Inc. stock is $11.78, while the 52 week low is $3.19 as of 9 Oct '26.

What is CING's market capitalisation today?

chevron-up
CING market capitalisation is $24.82M as of October 9, 2026, at 4:45 pm IST.

What is CING's net income for the last quarter?

chevron-up
CING's net income for the last quarter is -5.87B USD.

What is the 5 year returns of CING?

chevron-up
The 5 year returns of CING is -99.25% as on 9 Oct '26.

What is the high & low stock price of CING today?

chevron-up
CING stock price hit a high of $4.92 and low of $4.78 as of 9 Oct '26.

Can I buy CING shares in India?

chevron-up
Yes. You can buy CING in India by opening an international trading account.